SHINE Technologies, a next-generation nuclear technology company, and ImaginAb Inc., a market-leading global biotechnology company focused on developing next-generation immuno-oncology imaging agents and therapeutic...
A leader in nuclear technology obtains funding to produce medical isotopes in Europe and to help meet growing demands to provide diagnostic imaging for...